CorMedix Inc. Announces FDA Approval of DefenCath® to Reduce the Incidence of Catheter-Related Bloodstream Infections in Adult Hemodialysis Patients
Stock Information for Summit Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.